Chowdhury S - Search Results

1

An accelerated background subtraction algorithm for processing high-resolution MS data and its application to metabolite identification.

Shekar V, Shah A, Shadid M, Wu JT, Bolleddula J, Chowdhury S. Shekar V, et al. Among authors: chowdhury s. Bioanalysis. 2016 Aug;8(16):1693-707. doi: 10.4155/bio-2016-0101. Epub 2016 Jul 27. Bioanalysis. 2016. PMID: 27460980

2

Pharmacokinetics and Catabolism of [³H]TAK-164, a Guanylyl Cyclase C Targeted Antibody-Drug Conjugate.

Bolleddula J, Shah A, Shadid M, Kamali A, Smith MD, Chowdhury SK. Bolleddula J, et al. Drug Metab Dispos. 2020 Nov;48(11):1239-1245. doi: 10.1124/dmd.120.000194. Epub 2020 Aug 25. Drug Metab Dispos. 2020. PMID: 32843329

3

Determination of Acyl-, O-, and N-Glucuronide Using Chemical Derivatization Coupled with Liquid Chromatography-High-Resolution Mass Spectrometry.

Guo Y, Shah A, Oh E, Chowdhury SK, Zhu X. Guo Y, et al. Drug Metab Dispos. 2022 May;50(5):716-724. doi: 10.1124/dmd.122.000832. Epub 2022 Mar 3. Drug Metab Dispos. 2022. PMID: 35241454

4

Application of LC-high-resolution MS with 'intelligent' data mining tools for screening reactive drug metabolites.

Ma S, Chowdhury SK. Ma S, et al. Among authors: chowdhury sk. Bioanalysis. 2012 Mar;4(5):501-10. doi: 10.4155/bio.12.5. Bioanalysis. 2012. PMID: 22409549 Review.

5

Data acquisition and data mining techniques for metabolite identification using LC coupled to high-resolution MS.

Ma S, Chowdhury SK. Ma S, et al. Among authors: chowdhury sk. Bioanalysis. 2013 May;5(10):1285-97. doi: 10.4155/bio.13.103. Bioanalysis. 2013. PMID: 23721449 Review.

6

Carbon-carbon bond cleavage and formation reactions in drug metabolism and the role of metabolic enzymes.

Bolleddula J, Chowdhury SK. Bolleddula J, et al. Drug Metab Rev. 2015;47(4):534-57. doi: 10.3109/03602532.2015.1086781. Epub 2015 Sep 22. Drug Metab Rev. 2015. PMID: 26390887 Review.

7

Prediction of Human Disproportionate and Biliary Excreted Metabolites Using Chimeric Mice with Humanized Liver.

Kato S, Shah A, Plesescu M, Miyata Y, Bolleddula J, Chowdhury S, Zhu X. Kato S, et al. Among authors: chowdhury s. Drug Metab Dispos. 2020 Oct;48(10):934-943. doi: 10.1124/dmd.120.000128. Epub 2020 Jul 14. Drug Metab Dispos. 2020. PMID: 32665417

8

Biotransformation of [¹⁴C]-ixazomib in patients with advanced solid tumors: characterization of metabolite profiles in plasma, urine, and feces.

Pusalkar S, Plesescu M, Gupta N, Hanley M, Venkatakrishnan K, Wu JT, Xia C, Zhang X, Chowdhury S. Pusalkar S, et al. Among authors: chowdhury s. Cancer Chemother Pharmacol. 2018 Nov;82(5):803-814. doi: 10.1007/s00280-018-3671-z. Epub 2018 Aug 20. Cancer Chemother Pharmacol. 2018. PMID: 30128949 Clinical Trial.

9

Coupling of UHPLC with fast fraction collection-microplate scintillation counting and MS for radiolabeled metabolite profiling.

Tong W, Chowdhury S, Wrona M, Bateman K. Tong W, et al. Among authors: chowdhury s. Bioanalysis. 2012 Jun;4(11):1299-309. doi: 10.4155/bio.12.109. Bioanalysis. 2012. PMID: 22720649

10

Phase I study assessing the mass balance, pharmacokinetics, and excretion of [¹⁴C]-pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors.

Zhou X, Sedarati F, Faller DV, Zhao D, Faessel HM, Chowdhury S, Bolleddula J, Li Y, Venkatakrishnan K, Papai Z. Zhou X, et al. Among authors: chowdhury s. Invest New Drugs. 2021 Apr;39(2):488-498. doi: 10.1007/s10637-020-01017-x. Epub 2020 Oct 22. Invest New Drugs. 2021. PMID: 33089874 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,598 results

Search Page

Filters